Ladenburg Thalmann Financial Services’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $7K | Buy |
2,550
+800
| +46% | +$2.2K | ﹤0.01% | 4625 |
|
|
2019
Q3 | $6K | Hold |
1,750
| – | – | ﹤0.01% | 4591 |
|
|
2019
Q2 | $7K | Sell |
1,750
-500
| -22% | -$2K | ﹤0.01% | 4570 |
|
|
2019
Q1 | $7K | Sell |
2,250
-1,575
| -41% | -$4.9K | ﹤0.01% | 4511 |
|
|
2018
Q4 | $6K | Sell |
3,825
-300
| -7% | -$471 | ﹤0.01% | 4495 |
|
|
2018
Q3 | $11K | Sell |
4,125
-900
| -18% | -$2.4K | ﹤0.01% | 4218 |
|
|
2018
Q2 | $14K | Hold |
5,025
| – | – | ﹤0.01% | 4035 |
|
|
2018
Q1 | $14K | Hold |
5,025
| – | – | ﹤0.01% | 4035 |
|
|
2017
Q4 | $17K | Buy |
5,025
+200
| +4% | +$677 | ﹤0.01% | 3881 |
|
|
2017
Q3 | $20K | Buy |
4,825
+800
| +20% | +$3.32K | ﹤0.01% | 3671 |
|
|
2017
Q2 | $21K | Hold |
4,025
| – | – | ﹤0.01% | 3574 |
|
|
2017
Q1 | $23K | Buy |
4,025
+200
| +5% | +$1.14K | ﹤0.01% | 3456 |
|
|
2016
Q4 | $15K | Hold |
3,825
| – | – | ﹤0.01% | 3648 |
|
|
2016
Q3 | $14K | Hold |
3,825
| – | – | ﹤0.01% | 3606 |
|
|
2016
Q2 | $24K | Hold |
3,825
| – | – | ﹤0.01% | 3218 |
|
|
2016
Q1 | $19K | Buy |
3,825
+1,000
| +35% | +$4.97K | ﹤0.01% | 3277 |
|
|
2015
Q4 | $16K | Buy |
+2,825
| New | +$16K | ﹤0.01% | 3366 |
|